Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q96J92
UPID:
WNK4_HUMAN
Alternative names:
Protein kinase lysine-deficient 4; Protein kinase with no lysine 4
Alternative UPACC:
Q96J92; B0LPI0; Q8N8X3; Q8N8Z2; Q96DT8; Q9BYS5
Background:
Serine/threonine-protein kinase WNK4, also known as Protein kinase lysine-deficient 4, plays a pivotal role in the regulation of ion transport and blood pressure. It is a key component of the WNK4-SPAK/OSR1 kinase cascade, influencing the activity of various ion cotransporters and channels, thus affecting renal salt reabsorption and potassium secretion.
Therapeutic significance:
WNK4's involvement in Pseudohypoaldosteronism 2B, a disorder marked by hypertension and hyperkalemia, underscores its therapeutic potential. Targeting WNK4 could lead to innovative treatments for this condition, leveraging its role in modulating ion transport and blood pressure.